1. Home
  2. DERM
  3. DERM News

Latest Journey Medical Corporation (DERM) News on May 10, 2025

The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates
DERM

Zacks

a day ago

The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
DERM

GlobeNewswire

2 days ago

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?
DERM

Zacks

5 days ago

Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?

Why Journey Medical Corporation (DERM) is Surging in 2025
DERM

Insider Monkey

10 days ago

Why Journey Medical Corporation (DERM) is Surging in 2025

Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last?
DERM

Zacks

17 days ago

Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last?

Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now?
DERM

Insider Monkey

21 days ago

Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now?

Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?
DERM

Zacks

a month ago

Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?

DERM

MT Newswires

a month ago

Journey Medical Promotes Ramsey Alloush to COO

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
DERM

GlobeNewswire

a month ago

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

Journey Medical Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
DERM

Simply Wall St.

a month ago

Journey Medical Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

DERM

Thomson Reuters StreetEvents

a month ago

Q4 2024 Journey Medical Corp Earnings Call

DERM

GuruFocus.com

a month ago

Journey Medical Corp (DERM) Q4 2024 Earnings Call Highlights: Strategic Launch of Emrosi and ...

Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates
DERM

Zacks

a month ago

Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

a month ago

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corp (DERM) Q4 2024 Earnings Report Preview: What To Expect
DERM

GuruFocus.com

a month ago

Journey Medical Corp (DERM) Q4 2024 Earnings Report Preview: What To Expect

Journey Medical launches Emrosi for the treatment of rosacea
DERM

TipRanks

a month ago

Journey Medical launches Emrosi for the treatment of rosacea

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
DERM

GlobeNewswire

2 months ago

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025
DERM

GlobeNewswire

2 months ago

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference
DERM

GlobeNewswire

2 months ago

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
DERM

GlobeNewswire

2 months ago

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida
DERM

GlobeNewswire

2 months ago

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

Journey Medical Corporation (DERM): A Bull Case Theory
DERM

Insider Monkey

3 months ago

Journey Medical Corporation (DERM): A Bull Case Theory

Journey Medical Corporation's (NASDAQ:DERM) biggest owners are public companies who got richer after stock soared 32% last week
DERM

Simply Wall St.

3 months ago

Journey Medical Corporation's (NASDAQ:DERM) biggest owners are public companies who got richer after stock soared 32% last week

Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)
DERM

Insider Monkey

4 months ago

Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
DERM

GlobeNewswire

4 months ago

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Despite Journey Medical's Pullback, Insiders Still Gained US$118k
DERM

Simply Wall St.

6 months ago

Despite Journey Medical's Pullback, Insiders Still Gained US$118k

Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates
DERM

Zacks

6 months ago

Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

6 months ago

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

FDA approves Journey Medical’s rosacea treatment Emrosi
DERM

Pharmaceutical Technology

6 months ago

FDA approves Journey Medical’s rosacea treatment Emrosi

DERM

MT Newswires

6 months ago

Journey Medical Gets FDA Approval for Rosacea Treatment

Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?
DERM

Zacks

6 months ago

Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
DERM

GlobeNewswire

6 months ago

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
DERM

GlobeNewswire

6 months ago

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

DERM

ACCESSWIRE

7 months ago

SWK Holdings Provides Portfolio Update

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
DERM

GlobeNewswire

7 months ago

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns?
DERM

Simply Wall St.

7 months ago

Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns?

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
DERM

GlobeNewswire

8 months ago

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
DERM

GlobeNewswire

8 months ago

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Journey Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
DERM

Simply Wall St.

9 months ago

Journey Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Journey Medical Corporation (NASDAQ:DERM) Just Reported And Analysts Have Been Lifting Their Price Targets
DERM

Simply Wall St.

9 months ago

Journey Medical Corporation (NASDAQ:DERM) Just Reported And Analysts Have Been Lifting Their Price Targets

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

9 months ago

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates
DERM

Zacks

9 months ago

Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

9 months ago

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates
DERM

Zacks

9 months ago

Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024
DERM

GlobeNewswire

9 months ago

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
DERM

ACCESSWIRE

10 months ago

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

4D Molecular Therapeutics (FDMT) Moves 11.1% Higher: Will This Strength Last?
DERM

Zacks

10 months ago

4D Molecular Therapeutics (FDMT) Moves 11.1% Higher: Will This Strength Last?

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors
DERM

GlobeNewswire

10 months ago

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

Public companies are Journey Medical Corporation's (NASDAQ:DERM) biggest owners and were rewarded after market cap rose by US$26m last week
DERM

Simply Wall St.

a year ago

Public companies are Journey Medical Corporation's (NASDAQ:DERM) biggest owners and were rewarded after market cap rose by US$26m last week

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
DERM

GlobeNewswire

a year ago

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

DERM

GuruFocus.com

a year ago

Journey Medical Corp (DERM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Growth ...

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
DERM

GlobeNewswire

a year ago

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

DERM

ACCESSWIRE

a year ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
DERM

GlobeNewswire

a year ago

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)
DERM

GuruFocus.com

a year ago

Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)

Journey Medical Full Year 2023 Earnings: EPS Misses Expectations
DERM

Simply Wall St.

a year ago

Journey Medical Full Year 2023 Earnings: EPS Misses Expectations

DERM

Thomson Reuters StreetEvents

a year ago

Q4 2023 Journey Medical Corp Earnings Call

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA
DERM

Zacks

a year ago

Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
DERM

GlobeNewswire

a year ago

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
DERM

GlobeNewswire

a year ago

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

Journey Medical Insiders Up US$187k On US$520.8k Investment
DERM

Simply Wall St.

a year ago

Journey Medical Insiders Up US$187k On US$520.8k Investment

Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards?
DERM

Zacks

a year ago

Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards?

Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B
DERM

Zacks

a year ago

Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B

Community West Bancshares Reports Full Year Earnings and Declares Quarterly Cash Dividend of $0.08 Per Common Share
DERM

GlobeNewswire

a year ago

Community West Bancshares Reports Full Year Earnings and Declares Quarterly Cash Dividend of $0.08 Per Common Share

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.
DERM

PR Newswire

a year ago

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

Bay Commercial Bank (BCML) Lags Q4 Earnings Estimates
DERM

Zacks

a year ago

Bay Commercial Bank (BCML) Lags Q4 Earnings Estimates

West Bancorp Inc (WTBA) Reports Decline in Annual Net Income Amid Margin Challenges
DERM

GuruFocus.com

a year ago

West Bancorp Inc (WTBA) Reports Decline in Annual Net Income Amid Margin Challenges

NaaS Technology's Full Portfolio of Charging Pile Products Obtained CE Certification from the European Union
DERM

PR Newswire

a year ago

NaaS Technology's Full Portfolio of Charging Pile Products Obtained CE Certification from the European Union

American Superconductor (AMSC) Q3 Earnings and Revenues Top Estimates
DERM

Zacks

a year ago

American Superconductor (AMSC) Q3 Earnings and Revenues Top Estimates

Standard Lithium Advances South West Arkansas Project: Definitive Feasibility Study and Front-End Engineering Design Firm Chosen
DERM

GlobeNewswire

a year ago

Standard Lithium Advances South West Arkansas Project: Definitive Feasibility Study and Front-End Engineering Design Firm Chosen

LivePerson Adopts Tax Benefits Preservation Plan To Protect Valuable Tax Assets
DERM

PR Newswire

a year ago

LivePerson Adopts Tax Benefits Preservation Plan To Protect Valuable Tax Assets

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01
DERM

GlobeNewswire

a year ago

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

Genetron Health to Hold Extraordinary General Meeting of Shareholders
DERM

GlobeNewswire

a year ago

Genetron Health to Hold Extraordinary General Meeting of Shareholders

FAT Brands Makes West Coast Debut of Co-Branded Johnny Rockets and Hurricane Wings
DERM

GlobeNewswire

a year ago

FAT Brands Makes West Coast Debut of Co-Branded Johnny Rockets and Hurricane Wings

Franklin Covey Co. (NYSE:FC) Q1 2024 Earnings Call Transcript
DERM

Insider Monkey

a year ago

Franklin Covey Co. (NYSE:FC) Q1 2024 Earnings Call Transcript

Are Consumer Staples Stocks Lagging Coca-Cola (KO) This Year?
DERM

Zacks

a year ago

Are Consumer Staples Stocks Lagging Coca-Cola (KO) This Year?

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors
DERM

GlobeNewswire

a year ago

Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors

DERM

Business Wire

a year ago

Southland Awarded RFK Bridge Rehab & Other New Projects Totaling $470 Million

Ellomay Capital Enters into an Agreement to Sell the Talmei Yosef Solar Facility
DERM

PR Newswire

a year ago

Ellomay Capital Enters into an Agreement to Sell the Talmei Yosef Solar Facility

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

Are Investors Undervaluing Galiano Gold (GAU) Right Now?
DERM

Zacks

a year ago

Are Investors Undervaluing Galiano Gold (GAU) Right Now?

Smith-Midland Appoints New Members to its Board of Directors
DERM

ACCESSWIRE

a year ago

Smith-Midland Appoints New Members to its Board of Directors

Here's What Could Help Journey Medical Corporation (DERM) Maintain Its Recent Price Strength
DERM

Zacks

a year ago

Here's What Could Help Journey Medical Corporation (DERM) Maintain Its Recent Price Strength

The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics
DERM

Zacks

a year ago

The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics

What Awaits These 4 Drug Stocks That More Than Doubled in 2023?
DERM

Zacks

a year ago

What Awaits These 4 Drug Stocks That More Than Doubled in 2023?

Owning 44% shares,institutional owners seem interested in Smith-Midland Corporation (NASDAQ:SMID),
DERM

Simply Wall St.

a year ago

Owning 44% shares,institutional owners seem interested in Smith-Midland Corporation (NASDAQ:SMID),

Why CommScope Stock Was on Fire Today
DERM

Motley Fool

a year ago

Why CommScope Stock Was on Fire Today

argenx (ARGX) Tanks on Top-Line Data From Pemphigus Study
DERM

Zacks

a year ago

argenx (ARGX) Tanks on Top-Line Data From Pemphigus Study

IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial
DERM

GlobeNewswire

a year ago

IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial

GALIANO GOLD CONSOLIDATES OWNERSHIP OF THE ASANKO GOLD MINE IN TRANSFORMATIONAL TRANSACTION
DERM

PR Newswire

a year ago

GALIANO GOLD CONSOLIDATES OWNERSHIP OF THE ASANKO GOLD MINE IN TRANSFORMATIONAL TRANSACTION

Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA
DERM

Zacks

a year ago

Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA

4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow
DERM

Zacks

a year ago

4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow

ESSA Bancorp Full Year 2023 Earnings: Beats Expectations
DERM

Simply Wall St.

a year ago

ESSA Bancorp Full Year 2023 Earnings: Beats Expectations

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?
DERM

Zacks

a year ago

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

Share on Social Networks: